STAT3 and neoplasm: They also investigated STAT3 and PDL1 levels by primary tumor subtype and demonstrated an association between greater EV-associated STAT3 levels in breast cancer brain metastases patients, but lower EV-associated STAT3 levels in melanoma brain metastases patients alongside greater EV-associated PDL1 levels in melanoma brain metastases patients.